These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1128 related articles for article (PubMed ID: 7328599)

  • 1. Development of new mitomycin C and porfiromycin analogues.
    Iyengar BS; Lin HJ; Cheng L; Remers WA; Bradner WT
    J Med Chem; 1981 Aug; 24(8):975-81. PubMed ID: 7328599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin C and porfiromycin analogues with substituted ethylamines at position 7.
    Iyengar BS; Sami SM; Remers WA; Bradner WT; Schurig JE
    J Med Chem; 1983 Jan; 26(1):16-20. PubMed ID: 6827524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin C analogues with secondary amines at position 7.
    Iyengar BS; Sami SM; Tarnow SE; Remers WA; Bradner WT; Schurig JE
    J Med Chem; 1983 Oct; 26(10):1453-7. PubMed ID: 6620304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and antitumor activity of 7-substituted 1,2-aziridinomitosenes.
    Iyengar BS; Remers WA; Bradner WT
    J Med Chem; 1986 Oct; 29(10):1864-8. PubMed ID: 3761307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antineoplastic activity of 1a-formyl and 1a-thioformyl derivatives of mitomycin C and 2-methylaziridine.
    Fishbein PL; Kohn H
    J Med Chem; 1987 Oct; 30(10):1767-73. PubMed ID: 3116255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.
    Holden SA; Herman TS; Teicher BA
    Radiother Oncol; 1990 May; 18(1):59-70. PubMed ID: 2113698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of hematopoietic and leukemic colony-forming cells in vivo after administration of mitomycin C or porfiromycin.
    Razek A; Valeriote F; Vietti T
    J Natl Cancer Inst; 1973 Dec; 51(6):1845-8. PubMed ID: 4765389
    [No Abstract]   [Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides.
    Huh N; Rege AA; Yoo B; Kogan TP; Kohn H
    Bioconjug Chem; 1996; 7(6):659-69. PubMed ID: 8950485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of 6-substituted mitosene analogues of the mitomycins.
    Casner ML; Remers WA; Bradner WT
    J Med Chem; 1985 Jul; 28(7):921-6. PubMed ID: 3925147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
    EVANS JS; BOSTWICK L; MENGEL GD
    Biochem Pharmacol; 1964 Jul; 13():983-8. PubMed ID: 14201140
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative stereochemistry in the aziridine ring openings of N-methylmitomycin A and 7-methoxy-1,2-(N-methylaziridino)mitosene.
    Cheng L; Remers WA
    J Med Chem; 1977 Jun; 20(6):767-70. PubMed ID: 874953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New mitomycin analogs produced by directed biosynthesis.
    Claridge CA; Bush JA; Doyle TW; Nettleton DE; Moseley JE; Kimball D; Kammer MF; Veitch J
    J Antibiot (Tokyo); 1986 Mar; 39(3):437-46. PubMed ID: 3700245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and antitumor activity of additional mitomycin A analogues.
    Sami SM; Remers WA; Bradner WT
    J Med Chem; 1989 Mar; 32(3):703-8. PubMed ID: 2918519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin C analogues with aryl substituents on the 7-amino group.
    Sami SM; Iyengar BS; Tarnow SE; Remers WA; Bradner WT; Schurig JE
    J Med Chem; 1984 May; 27(5):701-8. PubMed ID: 6425501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of C-7 substituted cyclic acetal derivatives of mitomycin C and porfiromycin against hypoxic and oxygenated EMT6 carcinoma cells in vitro and in vivo.
    Rockwell S; Keyes SR; Loomis R; Kelley M; Vyas DM; Wong H; Doyle TW; Sartorelli AC
    Cancer Commun; 1991 Jun; 3(6):191-8. PubMed ID: 2049227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7-N-(mercaptoalkyl)mitomycins: implications of cyclization for drug function.
    Na Y; Wang S; Kohn H
    J Am Chem Soc; 2002 May; 124(17):4666-77. PubMed ID: 11971715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The derivation of 1a-demethylmitomycin G from mitomycin C.
    Kono M; Kasai M; Shirahata K; Morimoto M
    J Antibiot (Tokyo); 1990 Apr; 43(4):383-90. PubMed ID: 2112532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antineoplastic activity of mitosene analogues of the mitomycins.
    Hodges JC; Remers WA; Bradner WT
    J Med Chem; 1981 Oct; 24(10):1184-91. PubMed ID: 7328580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.